Ray Dalio's HRMY Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 251,506 shares of Harmony Biosciences Holdings, Inc. (HRMY) worth $7.04 M, representing 0.03% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Ray Dalio has maintained this position in HRMY for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 22,992 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Harmony Biosciences Holdings (HRMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Harmony Biosciences Holdings (HRMY) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +22,992 | Add 10.06% | 251,506 | $28.01 |
| Q4 2025 | +16,988 | Add 8.03% | 228,514 | $37.42 |
| Q3 2025 | +211,526 | New Buy | 211,526 | $27.56 |
Ray Dalio's Harmony Biosciences Holdings Investment FAQs
Ray Dalio first purchased Harmony Biosciences Holdings, Inc. (HRMY) in Q3 2025, acquiring 211,526 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Harmony Biosciences Holdings, Inc. (HRMY) for 3 quarters since Q3 2025.
Ray Dalio's largest addition to Harmony Biosciences Holdings, Inc. (HRMY) was in Q3 2025, adding 211,526 shares worth $5.83 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 251,506 shares of Harmony Biosciences Holdings, Inc. (HRMY), valued at approximately $7.04 M.
As of the Q1 2026 filing, Harmony Biosciences Holdings, Inc. (HRMY) represents approximately 0.03% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Harmony Biosciences Holdings, Inc. (HRMY) was 251,506 shares, as reported at the end of Q1 2026.